Skip to Content

Clorox Co

CLX: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$568.00YqzTvcrxrqbv

Clorox's Edge Should Prevail Despite Mounting Competition and a Muted Consumer Spending Backdrop

Business Strategy and Outlook

The fruits of Clorox's work to put pronounced inflationary headwinds and supply chain angst to rest were sidelined as a cybersecurity breach in mid-August forced it to take some information technology systems (including ordering) offline. Although this initially strangled sales and profits, we don’t surmise the firm’s competitive edge has been eroded. On the contrary, we think its entrenched standing with retailers will continue to enable it to build back its shelf position, similar to its inventory revival coming out of the pandemic.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CLX so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center